Search clinical trials for: Phase IIa

Total 19343 results

Merrimack Pharmaceuticals

Completed

Phase 2 Study of MM-093 to Treat Patients With Uveitis

Uveitis

United States
Maastricht University Medical Center

Unknown

Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase

Lower Urinary Tract Symptoms | Overactive Bladder Syndrome

Netherlands
Eisai Limited

Terminated

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma

Hepatocellular Carcinoma

Japan
University Hospital, Limoges

Unknown

Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid (ARABUL)

Bullous Pemphigoid

France
Pfizer

Completed

A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections

Infection

India
University of Minnesota
Cellular Sciences, inc.

Terminated

A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.

Cystic Fibrosis

United States
SkyePharma AG
Abbott

Completed

A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

Asthma

United States
PETHEMA Foundation

Completed

Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia

Chronic Myeloid Leukaemia

Spain
CASI Pharmaceuticals, Inc.

Completed

Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

Recurrent Glioblastoma Multiforme

United States
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
PowderMed

Completed

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

HSV-2

United States
Pfizer

Completed

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Smoking Cessation

United States, United Kingdom
YM BioSciences

Completed

Phase II Study of Inhaled AeroLEF for Analgesia After ACL Knee Surgery (Pain)

Pain | Post Operative Pain

Canada
Shizuoka Cancer Center

Unknown

Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer

Colorectal Cancer

Japan
DiObex

Terminated

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Type 2 Diabetes

Australia, United States, New Zealand
AstraZeneca

Completed

Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers (SAD)

Healthy Volunteers

Sweden
AstraZeneca

Completed

Determine the Effect of Multiple Doses of AZD7325, CYP Study (CYP)

Healthy Volunteer
University of Dundee
NHS Tayside; Chief Scientist Office of the Scottish Government

Completed

Medical Polypectomy and Predictors of Response

Nasal Polyps

United Kingdom
Memorial Sloan Kettering Cancer Center

Completed

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer | Metastatic Renal Cell Carcinoma

United States
AlphaVax, Inc.

Completed

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Influenza

United States
Aerovance, Inc.

Completed

A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects

Asthma

United Kingdom
St George's, University of London
Novartis Vaccines; Statens Serum Institut; European Union

Terminated

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (TMUVA-01)

Tuberculosis

United Kingdom
Memgen, LLC

Completed

A Phase I Extension Trial of Repeated Infusions of ISF35

Chronic Lymphocytic Leukemia

United States
Sun Yat-sen University

Completed

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

Kidney Diseases | Lupus Nephritis | Tacrolimus | Induction Phase | Maintenance Phase

China
Universidad de la Republica
Institute for Clinical Effectiveness and Health Policy; Unidad de Investigación...

Completed

Controlled Cord Traction During Third Stage of Labor (CCT)

Postpartum Hemorrhage

Uruguay
McGill University

Unknown

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

Cutaneous T-Cell Lymphoma

Canada
French Innovative Leukemia Organisation

Completed

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

Follicular Lymphoma

France
Memgen, LLC

Completed

A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)

Chronic Lymphocytic Leukemia

United States
Fudan University

Unknown

Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung

China
McGill University

Unknown

Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
McGill University

Unknown

Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Gastric Junction Adenocarcinoma

Canada
Karo Bio AB

Completed

Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Sweden
University Hospital Tuebingen
Hoffmann-La Roche

Completed

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Primary Gastric Diffuse-Large B-Cell Lymphoma

Germany
Cooperative Study Group A for Hematology

Unknown

A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL

Acute Lymphoblastic Leukemia

Korea, Republic of
Pfizer

Completed

Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase

Overactive Bladder

United States
GlaxoSmithKline

Completed

Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors

Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Sedation

Netherlands
Pfizer

Completed

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Spain, Italy
Herlev Hospital
Odense University Hospital

Unknown

A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer

Ovarian Cancer

Denmark
AstraZeneca

Completed

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

Bladder Cancer

Germany
GlaxoSmithKline

Completed

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Lymphoma | Solid Tumor Cancer

United States
GlaxoSmithKline

Completed

To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug

Healthy Subjects

United States
Bristol-Myers Squibb

Completed

Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

Cancer

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
University Hospital, Clermont-Ferrand

Completed

Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI

Myocardial Infarction | Ischemic Heart Disease

France
Johns Hopkins University

Completed

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

Pemphigus

United States
Assistance Publique - Hôpitaux de Paris
ARTIC group (oncologists and urologists association)

Unknown

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel (RisingPSA)

Adenocarcinoma of the Prostate

France
Eunice Kennedy Shriver National Institute of Child...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

HIV Infections | Pregnancy

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers

HIV Infections

United States

3

Subscribe